These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 16818925)

  • 21. Life style habits, biochemical factors and their interaction in the prediction of incident hypertension during 21-year follow-up.
    Terho A; Bloigu R; Bloigu A; Niemelä O; Tulppo M; Kesäniemi YA; Ukkola O
    Blood Press; 2019 Feb; 28(1):40-48. PubMed ID: 30479170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel protein glycan biomarker and future cardiovascular disease events.
    Akinkuolie AO; Buring JE; Ridker PM; Mora S
    J Am Heart Assoc; 2014 Sep; 3(5):e001221. PubMed ID: 25249300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relations between fasting serum lipids and high-sensitivity C-reactive protein level in Chengdu residents].
    Shu Y; He S; Chen XP; Lü ZB; Yang R; Liu K; Cui KJ; Huang DJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Feb; 40(2):125-30. PubMed ID: 22490712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
    [No Abstract]   [Full Text] [Related]  

  • 25. Association of very highly elevated C-reactive protein concentration with cardiovascular events and all-cause mortality.
    Hamer M; Chida Y; Stamatakis E
    Clin Chem; 2010 Jan; 56(1):132-5. PubMed ID: 19884487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.
    Suk Danik J; Rifai N; Buring JE; Ridker PM
    JAMA; 2006 Sep; 296(11):1363-70. PubMed ID: 16985228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoprotegerin improves risk detection by traditional cardiovascular risk factors and hsCRP.
    Mogelvang R; Haahr-Pedersen S; Bjerre M; Frystyk J; Iversen A; Galatius S; Flyvbjerg A; Jensen JS
    Heart; 2013 Jan; 99(2):106-10. PubMed ID: 23135978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.
    Zethelius B; Berglund L; Sundström J; Ingelsson E; Basu S; Larsson A; Venge P; Arnlöv J
    N Engl J Med; 2008 May; 358(20):2107-16. PubMed ID: 18480203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
    Ridker PM; Hennekens CH; Buring JE; Rifai N
    N Engl J Med; 2000 Mar; 342(12):836-43. PubMed ID: 10733371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors.
    Saito M; Ishimitsu T; Minami J; Ono H; Ohrui M; Matsuoka H
    Atherosclerosis; 2003 Mar; 167(1):73-9. PubMed ID: 12618270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores.
    Ridker PM; Cook N
    Circulation; 2004 Apr; 109(16):1955-9. PubMed ID: 15051634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
    Albert MA; Glynn RJ; Buring J; Ridker PM
    Circulation; 2006 Dec; 114(24):2619-26. PubMed ID: 17116764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?
    Yousuf O; Mohanty BD; Martin SS; Joshi PH; Blaha MJ; Nasir K; Blumenthal RS; Budoff MJ
    J Am Coll Cardiol; 2013 Jul; 62(5):397-408. PubMed ID: 23727085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lin JS; Evans CV; Johnson E; Redmond N; Coppola EL; Smith N
    JAMA; 2018 Jul; 320(3):281-297. PubMed ID: 29998301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between C-reactive protein, anthropometric and lipid parameters among healthy normal weight and overweight postmenopausal women in Montenegro.
    Klisic AN; Vasiljevic ND; Simic TP; Djukic TI; Maksimovic MZ; Matic MG
    Lab Med; 2014; 45(1):12-6. PubMed ID: 24719979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality.
    Parrinello CM; Lutsey PL; Ballantyne CM; Folsom AR; Pankow JS; Selvin E
    Am Heart J; 2015 Aug; 170(2):380-9. PubMed ID: 26299237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Cardiovascular Risk Factors for Coronary Heart Disease and Stroke Type in Women.
    Leening MJG; Cook NR; Franco OH; Manson JE; Lakshminarayan K; LaMonte MJ; Leira EC; Robinson JG; Ridker PM; Paynter NP
    J Am Heart Assoc; 2018 Oct; 7(19):e007514. PubMed ID: 30371339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventive cardiology: move over low density lipoprotein cholesterol, hello C-reactive protein?
    Genest J
    Can J Cardiol; 2004 Aug; 20 Suppl B():89B-92B. PubMed ID: 15309211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study.
    Muhlestein JB; May HT; Galenko O; Knowlton KU; Otvos JD; Connelly MA; Lappe DL; Anderson JL
    Am Heart J; 2018 Aug; 202():27-32. PubMed ID: 29803983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association Between Markers of Inflammation and Total Stroke by Hypertensive Status Among Women.
    Jiménez MC; Rexrode KM; Kotler G; Everett BM; Glynn RJ; Lee IM; Buring JE; Ridker PM; Sesso HD
    Am J Hypertens; 2016 Sep; 29(9):1117-24. PubMed ID: 27235695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.